New breakthrough in developing more personalized treatments for lung cancer
A study by the University of Barcelona has discovered why the two main types of lung cancer—adenocarcinoma of the lung and squamous cell carcinoma—respond differently to anti-angiogenic therapy, that is, drugs that block ...
2 minutes ago
0
0









